| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79c141015635d33651934c493e102bf1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate |
2014-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e94d9ed6ce1747851a7cfe97271f61a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01245d4a7636e25c4006093ac01e7469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f86126bdbb39ad9d646d6718e5e67a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c25c871490649968aaae1fe8befc17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac08ead0b896fb3d91cce783088efe5 |
| publicationDate |
2019-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3421033-A1 |
| titleOfInvention |
Hiv treatment formulation of atazanavir and cobicistat |
| abstract |
Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity. |
| priorityDate |
2013-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |